CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
September 20th 2023
Nine years of Pinktober while living with metastatic breast cancer.
119 Reasons Why Metastatic Breast Cancer Awareness Day Matters
October 13th 2021I am in awe of what scientists have been able to discover, but we don’t know enough for those 119 women who will die this Metastatic Breast Cancer Awareness Day, nor for the 43,881 others who will die before the next Breast Cancer Awareness Month rolls around. We deserve more.
A Caregiver's Wishes for a Woman With Metastatic Breast Cancer
August 23rd 2021A caregiver discusses her wishes for a woman who was recently diagnosed with metastatic breast cancer. “Most of all I wish that time will stand still for her, so that she can crawl into bed with her children and hold them as long as she wants to, feeling their bodies curl into hers as they sleep,” she writes.
Progression of HER2+ Metastatic Breast Cancer
March 30th 2021Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, shares the hope she had after progression because of the ongoing research for HER2+ breast cancer, and Sara A. Hurvitz, M.D., reviews the drug regimens available in this realm.
Emerging Therapies Show Promise in Treating Metastatic Breast Cancer
March 16th 2021An expert discusses the potential that several novel therapies hold in treating metastatic breast cancer, including PARP inhibitors, immunotherapy and antibody drug conjugates. Each therapy type has an FDA-approved option to potentially provide patients with better outcomes and quality of life.
FDA to Evaluate Status of 6 Cancer Drug Indications That Were Granted Accelerated Approvals
March 14th 2021The FDA announced that a special committee will review the indications of several cancer drugs that were granted accelerated approval as confirmatory trials showed they failed to demonstrate efficacy.